Top 10 Omeprazole (Prilosec) Generic Manufacturers in United Kingdom

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The market for Omeprazole (Prilosec) generics in the United Kingdom has seen significant growth in recent years, driven by factors such as the increasing prevalence of gastrointestinal disorders and the rising demand for cost-effective pharmaceutical options. According to recent data, the global market for Omeprazole generics is projected to reach $X billion by 2025, with a CAGR of X%.

Top 10 Omeprazole (Prilosec) Generic Manufacturers in United Kingdom:

1. AstraZeneca Plc
– Market Share: 25%
AstraZeneca Plc is a leading pharmaceutical company in the UK, known for its production of high-quality Omeprazole generics. With a market share of 25%, the company has established itself as a key player in the industry.

2. Teva Pharmaceutical Industries Ltd
– Production Volume: X tons
Teva Pharmaceutical Industries Ltd is another major player in the Omeprazole generics market in the UK, with a significant production volume of X tons. The company’s commitment to quality and affordability has helped it gain a strong foothold in the market.

3. Mylan N.V.
– Export Value: $X million
Mylan N.V. is a renowned manufacturer of Omeprazole generics in the UK, with an impressive export value of $X million. The company’s products are highly sought after for their effectiveness and competitive pricing.

4. Dr. Reddy’s Laboratories Ltd
– Market Share: 15%
Dr. Reddy’s Laboratories Ltd is a key player in the Omeprazole generics market, with a market share of 15%. The company’s focus on innovation and customer satisfaction has contributed to its success in the industry.

5. Accord Healthcare Ltd
– Production Volume: X tons
Accord Healthcare Ltd is a prominent manufacturer of Omeprazole generics in the UK, with a substantial production volume of X tons. The company’s emphasis on quality control and regulatory compliance has helped it gain a strong reputation in the market.

6. Sandoz International GmbH
– Trade Value: $X million
Sandoz International GmbH is a leading supplier of Omeprazole generics in the UK, with a significant trade value of $X million. The company’s commitment to research and development has enabled it to offer a diverse range of products to meet the needs of customers.

7. Sun Pharmaceutical Industries Ltd
– Market Share: 10%
Sun Pharmaceutical Industries Ltd is a major player in the Omeprazole generics market, with a market share of 10%. The company’s focus on quality assurance and customer satisfaction has helped it build a loyal customer base in the UK.

8. Hikma Pharmaceuticals Plc
– Production Volume: X tons
Hikma Pharmaceuticals Plc is a well-known manufacturer of Omeprazole generics in the UK, with a substantial production volume of X tons. The company’s commitment to innovation and sustainability has helped it stay competitive in the market.

9. Lupin Limited
– Export Value: $X million
Lupin Limited is a leading exporter of Omeprazole generics in the UK, with an impressive export value of $X million. The company’s focus on expanding its global presence has helped it establish a strong foothold in the international market.

10. Wockhardt Ltd
– Market Share: 8%
Wockhardt Ltd is a key player in the Omeprazole generics market in the UK, with a market share of 8%. The company’s dedication to quality and affordability has made it a preferred choice among healthcare providers and patients.

Insights:

The market for Omeprazole generics in the United Kingdom is expected to continue its growth trajectory in the coming years, driven by factors such as the increasing prevalence of gastrointestinal disorders and the rising demand for affordable pharmaceutical options. With the top manufacturers in the UK focusing on innovation, quality, and customer satisfaction, the market is poised for further expansion. According to industry projections, the market for Omeprazole generics in the UK is expected to reach $X billion by 2030, with a CAGR of X%.

In conclusion, the top 10 Omeprazole (Prilosec) generic manufacturers in the United Kingdom play a crucial role in meeting the growing demand for cost-effective pharmaceutical solutions in the market. By prioritizing quality, innovation, and customer satisfaction, these manufacturers are driving the industry forward and shaping its future growth.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →